Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression

Pankaj Trivedi, Kumi Takazawa, Claudia Zompetta, Laura Cuomo, Elena Anastasiadou, Antonino Carbone, Stefania Uccini, Filippo Belardelli, Kenzo Takada, Luigi Frati, Alberto Faggioni

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

To investigate the role of Epstein-Barr virus (EBV) in the pathogenesis of primary effusion lymphoma (PEL), we infected human herpesvirus 8 (HHV-8 +) but EBV- PEL lines BC-3, CRO-AP/6, and CRO-AP/3 cells with the recombinant Akata EBV strain. All EBV-infected clones expressed EBER-1, EBNA-1, and LMP2A. The expression of LMP1 and LMP2B was variable. None, however, expressed EBNA2-6. The surface markers CD30, CD74, and syndecan-1 were down-regulated in EBV convertants. EBV-infected BC-3 and CRO-AP/6 cells were highly tumorigenic in severe combined immunodeficiency (SCID) mice in contrast to their respective EBV-parental cells. However, neither the parental cells nor the virusconverted counterparts expressed TCL1. The results showing that PEL cells on in vitro EBV infection do not sustain latency III despite the absence of immune pressure indicate that the choice of EBV latent gene expression program is cell dependent. The data suggest an important role of EBV in the pathogenesis of PEL.

Original languageEnglish
Pages (from-to)313-316
Number of pages4
JournalBlood
Volume103
Issue number1
DOIs
Publication statusPublished - Jan 1 2004

Fingerprint

Primary Effusion Lymphoma
Virus Latency
Human Herpesvirus 8
Human Herpesvirus 4
Viruses
Phenotype
Infection
Cathode ray oscilloscopes
Syndecan-1
Severe Combined Immunodeficiency
Epstein-Barr Virus Infections
Gene expression
Clone Cells

ASJC Scopus subject areas

  • Hematology

Cite this

Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression. / Trivedi, Pankaj; Takazawa, Kumi; Zompetta, Claudia; Cuomo, Laura; Anastasiadou, Elena; Carbone, Antonino; Uccini, Stefania; Belardelli, Filippo; Takada, Kenzo; Frati, Luigi; Faggioni, Alberto.

In: Blood, Vol. 103, No. 1, 01.01.2004, p. 313-316.

Research output: Contribution to journalArticle

Trivedi, Pankaj ; Takazawa, Kumi ; Zompetta, Claudia ; Cuomo, Laura ; Anastasiadou, Elena ; Carbone, Antonino ; Uccini, Stefania ; Belardelli, Filippo ; Takada, Kenzo ; Frati, Luigi ; Faggioni, Alberto. / Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression. In: Blood. 2004 ; Vol. 103, No. 1. pp. 313-316.
@article{22321f9a17ea4e398475dafe74c6bad0,
title = "Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression",
abstract = "To investigate the role of Epstein-Barr virus (EBV) in the pathogenesis of primary effusion lymphoma (PEL), we infected human herpesvirus 8 (HHV-8 +) but EBV- PEL lines BC-3, CRO-AP/6, and CRO-AP/3 cells with the recombinant Akata EBV strain. All EBV-infected clones expressed EBER-1, EBNA-1, and LMP2A. The expression of LMP1 and LMP2B was variable. None, however, expressed EBNA2-6. The surface markers CD30, CD74, and syndecan-1 were down-regulated in EBV convertants. EBV-infected BC-3 and CRO-AP/6 cells were highly tumorigenic in severe combined immunodeficiency (SCID) mice in contrast to their respective EBV-parental cells. However, neither the parental cells nor the virusconverted counterparts expressed TCL1. The results showing that PEL cells on in vitro EBV infection do not sustain latency III despite the absence of immune pressure indicate that the choice of EBV latent gene expression program is cell dependent. The data suggest an important role of EBV in the pathogenesis of PEL.",
author = "Pankaj Trivedi and Kumi Takazawa and Claudia Zompetta and Laura Cuomo and Elena Anastasiadou and Antonino Carbone and Stefania Uccini and Filippo Belardelli and Kenzo Takada and Luigi Frati and Alberto Faggioni",
year = "2004",
month = "1",
day = "1",
doi = "10.1182/blood-2003-05-1710",
language = "English",
volume = "103",
pages = "313--316",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression

AU - Trivedi, Pankaj

AU - Takazawa, Kumi

AU - Zompetta, Claudia

AU - Cuomo, Laura

AU - Anastasiadou, Elena

AU - Carbone, Antonino

AU - Uccini, Stefania

AU - Belardelli, Filippo

AU - Takada, Kenzo

AU - Frati, Luigi

AU - Faggioni, Alberto

PY - 2004/1/1

Y1 - 2004/1/1

N2 - To investigate the role of Epstein-Barr virus (EBV) in the pathogenesis of primary effusion lymphoma (PEL), we infected human herpesvirus 8 (HHV-8 +) but EBV- PEL lines BC-3, CRO-AP/6, and CRO-AP/3 cells with the recombinant Akata EBV strain. All EBV-infected clones expressed EBER-1, EBNA-1, and LMP2A. The expression of LMP1 and LMP2B was variable. None, however, expressed EBNA2-6. The surface markers CD30, CD74, and syndecan-1 were down-regulated in EBV convertants. EBV-infected BC-3 and CRO-AP/6 cells were highly tumorigenic in severe combined immunodeficiency (SCID) mice in contrast to their respective EBV-parental cells. However, neither the parental cells nor the virusconverted counterparts expressed TCL1. The results showing that PEL cells on in vitro EBV infection do not sustain latency III despite the absence of immune pressure indicate that the choice of EBV latent gene expression program is cell dependent. The data suggest an important role of EBV in the pathogenesis of PEL.

AB - To investigate the role of Epstein-Barr virus (EBV) in the pathogenesis of primary effusion lymphoma (PEL), we infected human herpesvirus 8 (HHV-8 +) but EBV- PEL lines BC-3, CRO-AP/6, and CRO-AP/3 cells with the recombinant Akata EBV strain. All EBV-infected clones expressed EBER-1, EBNA-1, and LMP2A. The expression of LMP1 and LMP2B was variable. None, however, expressed EBNA2-6. The surface markers CD30, CD74, and syndecan-1 were down-regulated in EBV convertants. EBV-infected BC-3 and CRO-AP/6 cells were highly tumorigenic in severe combined immunodeficiency (SCID) mice in contrast to their respective EBV-parental cells. However, neither the parental cells nor the virusconverted counterparts expressed TCL1. The results showing that PEL cells on in vitro EBV infection do not sustain latency III despite the absence of immune pressure indicate that the choice of EBV latent gene expression program is cell dependent. The data suggest an important role of EBV in the pathogenesis of PEL.

UR - http://www.scopus.com/inward/record.url?scp=9144249086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144249086&partnerID=8YFLogxK

U2 - 10.1182/blood-2003-05-1710

DO - 10.1182/blood-2003-05-1710

M3 - Article

C2 - 12969959

AN - SCOPUS:9144249086

VL - 103

SP - 313

EP - 316

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -